MeAgain
Radically Accessible GLP-1 Care
- Headquarters
- New York, New York
- Employees
- 1–10
- Business Model
- B2C
- Website
- meagain.com
About
MeAgain is a GLP-1 companion app that helps users track their daily medication dose, side effects, food intake, hydration, and habits throughout their weight-loss journey. The app provides severity-rated side effect logging with custom symptom tracking, enabling users to connect symptoms to dose timing, meals, and water intake for better-informed conversations with their healthcare providers. MeAgain is designed to make GLP-1 care radically accessible, offering a simple but comprehensive toolkit for people using Ozempic and other GLP-1 medications.
Summary
MeAgain is a Healthcare company based in New York.
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Healthcare company in Europe